Hofmann, W.-P., Mauss, S., Lutz, T., Schober, A., Böker, K.H.W., Moog, G., Baumgarten, A., Pfeiffer-Vornkahl, H., Alshuth, U., Hüppe, D., Wedemeyer, H., Manns, M.P. und Schott, E. (ohne Datum) „Benefit of treatment individualization in patients with chronic hepatitis C receiving peginterferon alfa-2 a and ribavirin in a large noninterventional cohort study“, PLOS ONE, (Band 10, Heft 7 (2015), S. , Heft 7 (2015). doi:10.1371/journal.pone.0134839.

Hofmann, Wolf-Peter, Stefan Mauss, Thomas Lutz, Andreas Schober, Klaus H. W. Böker, Gero Moog, Axel Baumgarten, Heike Pfeiffer-Vornkahl, Ulrich Alshuth, Dietrich Hüppe, Heiner Wedemeyer, Michael P. Manns, und Eckart Schott. „Benefit of treatment individualization in patients with chronic hepatitis C receiving peginterferon alfa-2 a and ribavirin in a large noninterventional cohort study“. Electronic. PLOS ONE, Nr. Band 10, Heft 7 (2015) (o. J.): , Heft 7 (2015). https://doi.org/10.1371/journal.pone.0134839.

Hofmann, W.-P., Mauss, S., Lutz, T., Schober, A., Böker, K. H. W., Moog, G., Baumgarten, A., Pfeiffer-Vornkahl, H., Alshuth, U., Hüppe, D., Wedemeyer, H., Manns, M. P., & Schott, E. (o. J.). Benefit of treatment individualization in patients with chronic hepatitis C receiving peginterferon alfa-2 a and ribavirin in a large noninterventional cohort study [Electronic]. PLOS ONE, Band 10, Heft 7 (2015), , Heft 7 (2015). https://doi.org/10.1371/journal.pone.0134839

Hofmann, W.-P., S. Mauss, T. Lutz, A. Schober, K. H. W. Böker, G. Moog, A. Baumgarten, H. Pfeiffer-Vornkahl, U. Alshuth, D. Hüppe, H. Wedemeyer, M. P. Manns, und E. Schott. „Benefit of treatment individualization in patients with chronic hepatitis C receiving peginterferon alfa-2 a and ribavirin in a large noninterventional cohort study“. PLOS ONE, electronic, Nr. Band 10, Heft 7 (2015), [Universitätsbibliothek Johann Christian Senckenberg] San Francisco, California, US : PLOS, 2006-, S. , Heft 7 (2015), https://doi.org/10.1371/journal.pone.0134839.

HOFMANN, Wolf-Peter, Stefan MAUSS, Thomas LUTZ, Andreas SCHOBER, Klaus H. W. BÖKER, Gero MOOG, Axel BAUMGARTEN, Heike PFEIFFER-VORNKAHL, Ulrich ALSHUTH, Dietrich HÜPPE, Heiner WEDEMEYER, Michael P. MANNS und Eckart SCHOTT, [kein Datum]. Benefit of treatment individualization in patients with chronic hepatitis C receiving peginterferon alfa-2 a and ribavirin in a large noninterventional cohort study. PLOS ONE. Nr. Band 10, Heft 7 (2015), S. , Heft 7 (2015). DOI 10.1371/journal.pone.0134839